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Mn-Salen Catalysed Benzylic C-H Activation for the 
Synthesis of Aryl [18F]CF3-containing PET probes 
L. Carroll,a H. L. Evans,a A. C. Spiveyb and E. O. Aboagyea 
 
 
The development of a Mn-salen complex catalysed oxidative 
benzylic fluorination of non-activated C-H bonds using 
[18F]fluoride is described for installation of [18F]CHRF, 
[18F]CR2F and particularly [18F]CF3 containing groups in the 
presence of other functional groups. 
 
PET is a non-invasive molecular imaging modality which 
allows the in vivo imaging of a variety of biological processes 
in patients. Of the leading PET radioisotopes currently 
available, fluorine-18 (18F) is one of the most important, as 
evidenced by the numerous clinically-deployed 18F radiotracers. 
These tracers include 2-[18F]fluorodeoxyglucose ([18F]FDG), 
3′-deoxy-3′-[18F]fluorothymidine ([18F]FLT) and 
[18F]fluorodopa, which are widely used in the fields of 
oncology and neurology.[1-4] While there has been an increase 
in the number of 18F-containing pre-clinical radiotracers and 
new methods for the attachment of 18F-containing prosthetic 
groups to target molecules, the initial incorporation of 
[18F]fluoride is in most cases still achieved by classical 
nucleophilic substitution reactions (i.e., via SN2 or SNAr 
mechanisms). Recently however, protocols for the preparation 
of [18F] aryl fluorides from aryl iodoniumsalts,[5],[6] and by the 
use of Pd(IV) and Ni(II) complexes,[7] [18F]allylic ﬂuorides by 
Pd-catalysed substitution, [18F]4-ﬂuorophenols by oxidative 
ﬂuorination,[8] and [18F]trifluoromethyl aromatics catalysed by 
copper,[9] have been described that bypass these traditional 
radiofluorination paradigms. Moreover, Groves et al. have very 
recently disclosed an appealing method for direct oxidative 
[18F]fluorination at benzylic methylene C-H positions using 
[18F]fluoride using a Mn(salen)OTs pre-catalyst.[10-12], This 
report has prompted us to disclose a related procedure that we 
have developed and applied with particular success for the 
fluorination of aryl difluoromethyl compounds as an efficient 
approach to [18F]labelled trifluoro aryl PET probes. 
  
 Selecting to work with Jacobsen-type pre-catalyst (±)-1 and 
with iodosobenzene as stoichiometric oxidant due to their 
commercially availability, our initial objective was to define 
optimal conditions for the benzylic oxidative [18F] fluorination 
of 1-ethylnapthalene 2a by [18F] fluoride  (Table 1).[13]  
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Entry Solvent PhIO[c] T/oC Time %RCI[d] 
1 MeCN[a] P 60 15 27 
2 MeCN/MeOH[a] P 60 30 trace 
3 MeCN/t-BuOH[a] P 60 15 25 
4 MeCN/DMF[a] P 60 15 2 
5 MeCN[b] P 60 30 72 
6 MeCN[b] S 60 30 32 
7 MeCN[b] S 90 30 28 
8[e MeCN[b] P 60 30 70 
[a][substrate] = 0.3 M; [b][substrate] = 0.1 M; [c]Method of PhIO addition, 
either P = in equal portions at 5 min intervals, N = None used or S = 
Single addition; [d]RCI = Radiochemical Incorporation, calculated from 
radio-HPLC analysis, n = 3 in each example; [e] Kryptofix 2.2.2. (K222) 
used instead of 18-c-6. 
Table 1 – Optimisation of the oxidative [18F] fluorination of 1-
ethylnaphthalene 2a. 
A combination of different solvents, temperatures durations and 
protocols for addition of the PhIO were explored. Portion-wise 
addition of solid PhIO gave a promising radiochemical 
incorporation of 27% within 15 minutes (n = 3; entry 1). As 
PhIO is only sparingly soluble in most organic solvents, and 
full dissolution is critical for automated radiosynthesis, we 
explored the use of a co-solvent. Use of either MeOH or DMF 
as co-solvents (1:1 v/v) allowed complete dissolution of the 
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oxidant, but supressed product formation (entries 2 and 4) 
whereas t-BuOH was ineffective as a co-solvent and gave 
identical levels of incorporation to when using MeCN alone 
(entry 3 cf. entry 1). Reverting to the use of just MeCN as 
solvent but with increased dilution (0.1 M cf. 0.3 M) we were 
pleased to observe that after a reaction time of 30 minutes 72% 
radiochemical incorporation could be achieved (entry 5). At 
this dilution, addition of the PhIO solution as a single portion 
gave 32% RCI after 30 min, which we considered adequate for 
compound labelling (entry 6). Increasing the temperature to 90 
°C gave no discernible improvement in incorporation (entry 7) 
and replacement of 18-c-6 with Kryptofix© 2.2.2 (K222) had no 
significant influence on the level of RCI (entry 8). 
 Application of this reaction to several simple substrates was 
undertaken to delineate the scope of the method (Figure 1). 
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Figure 1 - Oxidative benzylic [18F] fluorination of several 
different compounds using optimised labelling conditions, n = 
4. 
Successful labelling of compounds was achieved with moderate 
to good levels of incorporation in most cases. In general, 
secondary fluorides were introduced efficiently, whereas 
introduction at a primary position gave less than 5% RCY 
([18F]3c) and at a tertiary position gave a more promising 14% 
RCY ([18F]3d). Site-selective labelling to give phenylalanine 
derivative [18F]3e gave 49% RCY although no 
diastereoselectivity was observed. 
 Notwithstanding the attraction of installing a single fluorine 
atom site-selectively within a target molecule, labelling of CF3 
groups was of particular interest due to their occurrence in a 
number of pharmaceuticals and we anticipated that 18F-
labelling of a difluoromethyl group could be an attractive entry 
to labelled CF3 units.14 The benzylic difluoromethyl containing 
precursors required for this approach are readily prepared by 
fluorodeoxygenation of benzaldehydes or by copper-catalysed 
difluoromethylation of aryl iodides using TMS-CF2CO2Et (or 
TMS-CF2H).[15-17] 
 Ten benzylic difluoromethyl substrates also containing 
other potentially reactive functional groups (i.e. ether, aryl 
halide and carbamate groups) were investigated (Figure 2).  
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Figure 2 - 18F Oxidative benzylic fluorination to give CF3-
containing compounds, n = 3. 
[18F]Trifluoromethylbenzene ([18F]3f) and its 4- and 2-
brominated derivatives [18F]3g and [18F]3h were prepared in 
27%, 44% and 54% RCYs respectively whereas the more 
electron deficient 4-nitro and 3-cyano derivatives [18F]3i and 
[18F]3j were much less efficiently labelled (1% and 8% RCY 
respectively). It appears therefore that although strongly 
electron withdrawing substituents deter [18F]fluorine trapping 
of the presumed radical intermediate, bulky 2-substituents are 
tolerated. This is consistent with the successful formation of 
isomeric 2- and 4-substituted biaryls [18F]3m and [18F]3n and 
of 4- substituted biaryls [18F]3k, [18F]3l nd [18F]3o in 36%, 
61%, 16%, 42% and 34% RCYs respectively.  
 Labelled bromophenyls [18F]3g and [18F]3h can also be 
deployed as prosthetic groups as illustrated by the prepation of 
biaryl [18F]3k and [18F]3j by Suzuki coupling (Scheme 1). 
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Scheme 1 – Synthesis of biaryls [18F] 3k and 3o from [18F]3g 
by Suzuki coupling, n = 3. 
 The specific radioactivity of a labelled probe, quantifies the 
amount of radioactivity relative to non-labelled material 
present, and constitutes an important property of the probe. For 
the synthesis of [18F]3g, the specific activity was ~4 GBq/µmol, 
starting from 190 MBq of starting [18F]fluoride. This level of 
specific activity is ~10 fold greater than that reported by 
Huiban et al. for their [18F]CF3 labelling.[9] 
 We also performed ICP-MS analysis on a purified sample 
of [18F]3a which had been allowed to decay, and no manganese 
was detected (<0.01 mg/l). Unlike Pd, which has a non-dietary 
limit of 100 µg/day for a 50 Kg adult, Mn is essential for 
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various functions in the human body and a daily intake of 2.5 
mg/day is recommended for a 50 Kg adult. [18] 
 Mechanistically, we anticipate that the [18F]labelling 
reaction proceeds via essentially the same catalytic cycle as 
proposed by Liu and Groves for their 18F labelling using 
Mn(salen)OTs (Figure 5).[11]  
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Figure 5 – Proposed catalytic cycle for the 18F-labelling 
reaction, and side-reaction to form alcohol by-products. 
Thus, following initial Cl to OTf ligand exchange at Mn(III) 
effected by the AgOTf, [18F]fluoride is introduced via ligand 
exchange (→ 4). Oxidation by PhIO then gives Mn(V) oxo 
species 5 which effecs hydrogen atom abstraction from a 
benzylic position on the substrate concomitantly forming 
fluorohydroxy-manganese(IV) species 6 (X = 18F). This species 
then ‘rebounds’ the [18F]fluorine atom to the benzylic carbon 
cetred radical to give the labelled product. Due to the low 
concentration of [18F]fluoride, hydroxide can presumably 
compete as a ligand at Mn giving e.g. the 
dihydroxymanganese(IV) intermediate 6 (X = OH), hydroxide 
radical ‘rebound’ from which would give alcohol side-products, 
as are observed in these reactions. 
Conclusions 
We have described a new method for radiolabelling via site-
selective oxidative fluorination of benzylic difluoromethyl 
groups using [18F]fluoride to give aryl [18F]CF3 compounds. 
The labelling reactions can be achieved without extensive 
investment in complex precursors and the straightforward 
experimental protocol holds promise for adaption to automated 
clinical PET probe production. 
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